Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Non-Current Assets came in at $657.5 million in Q2 2026, down 7.13% on a YoY basis from $708.0 million in Q2 2025, and up 5.52% quarter-over-quarter from $623.1 million in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Non-Current Assets for 7 consecutive years, with $657.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 7.13% year-over-year to $657.5 million; the trailing twelve-month figure through Jun 2026 stood at $2.6 billion (down 13.81% YoY), and the FY2025 full-year result was $647.9 million, down 16.37% from the prior year.
- Non-Current Assets advanced to $657.5 million in Q2 2026 per DNA's latest filing, from $623.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2023 and bottomed at $351.9 million in Q1 2022.
- Historically, Non-Current Assets has averaged $728.6 million across 5 years, with a median of $695.5 million in 2025.
- The widest YoY moves for Non-Current Assets: up 213.05% in 2022, down 79.6% in 2022.
- Over 5 years, Non-Current Assets stood at $1.1 billion in 2022, then slumped by 39.08% to $663.6 million in 2023, then rose by 16.74% to $774.7 million in 2024, then declined by 16.37% to $647.9 million in 2025, then increased by 1.49% to $657.5 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $657.5 million, $623.1 million, and $647.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.22 Bn | 40.14 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 16.45 Bn | 15.95 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Charles River Laboratories International | 13.14 Bn | 12.95 Bn | 452.07 Mn | 6.00 Bn |
| 4 | Icon | 12.38 Bn | 11.45 Bn | 479.29 Mn | 12.65 Bn |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 418.69 Mn | 334.15 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 71.79 Mn | 71.79 Mn | 7.03 Mn | 7.77 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 3.76 Mn |
| 10 | VivoSim Labs | 1.44 Mn | 1.44 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 657.51 Mn |
| Mar 31, 2026 | 623.12 Mn |
| Dec 31, 2025 | 647.86 Mn |
| Sep 30, 2025 | 683.08 Mn |
| Jun 30, 2025 | 707.98 Mn |
| Mar 31, 2025 | 728.93 Mn |
| Dec 31, 2024 | 774.71 Mn |
| Sep 30, 2024 | 818.40 Mn |
| Jun 30, 2024 | 841.89 Mn |
| Mar 31, 2024 | 678.74 Mn |
| Dec 31, 2023 | 663.59 Mn |
| Sep 30, 2023 | 884.55 Mn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 1.09 Bn |
| Sep 30, 2022 | 408.69 Mn |
| Jun 30, 2022 | 395.37 Mn |
| Mar 31, 2022 | 351.89 Mn |
| Dec 31, 2021 | 347.95 Mn |
| Sep 30, 2021 | 340.02 Mn |